期刊
HAEMOPHILIA
卷 19, 期 3, 页码 409-414出版社
WILEY
DOI: 10.1111/hae.12110
关键词
haemophilia A; rFVIII prophylaxis; TEG; thrombin generation assay
类别
资金
- Virginia Commonwealth University
- General Clinical Research Center, NCR, National Institutes of Health, Bethesda, MD, USA [M01 RR00065]
Secondary factor VIII (FVIII) prophylaxis converts severe haemophiliacs (FVIII:C<1IUdL1) to a moderate phenotype (FVIII:C1IUdL1), however, plasma FVIII:C is a poor predictor of bleeding risk. This study used thromboelastography (TEG) and thrombin generation assay (TGA) to quantify coagulation across a 48h rFVIII prophylaxis period. 10 severe haemophiliacs with varying clinical bleeding phenotypes received their standard rFVIII prophylaxis dose and blood samples were obtained over 48h. Measured parameters included FVIII:C, TEG and TGA at each time point. FVIII:C pharmacokinetics (PK) and correlation between global assay parameters was performed. The FVIII:C PK parameters were consistent with previous literature. There was significant correlation between FVIII:C and TEG R-time and aPTT (both P<0.001). Significant correlations existed between FVIII:C and TGA peak, ETP and velocity parameters (all P<0.001). At 24h the TEG parameters were sub-therapeutic despite median FVIII:C of 13.0IUdL1. TGA was sensitive to FVIII:C below 1IUdL1. Those with the severest bleeding phenotype had the lowest TGA parameters. There was significant correlation between FVIII:C and TEG and TGA. TEG lost sensitivity at 48h, but not TGA. Prospective studies are needed to determine whether these data can be used to design individualized rFVIII prophylaxis regimens.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据